DexCom Inc. (DXCM)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q2 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 16,664 | 0.04 | |
| Q4 2023 | |||||
| ≡ | Chase Coleman - Tiger Global Management | Buy | 1,152,806 | 1.02 | |
| Q3 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 11,761 | 0.03 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 1021.76% | 10,708 | 0.01 | |
| ≡ | Stephen Mandel - Lone Pine Capital | Add 4.64% | 421,356 | 0.14 | |
| Q4 2020 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Add 389.72% | 7,218,888 | 2.43 | |
| Q3 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 1,448 | 0.00 | |
| ≡ | Stephen Mandel - Lone Pine Capital | Add 36.38% | 494,164 | 0.22 | |
| Q2 2020 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Buy | 1,358,184 | 0.71 | |
| Q4 2019 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Buy | 4,235,580 | 1.24 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.